Surgical Incision Closure Method to Prevent Niche Formation After Cesarean Section- Randomized Controlled Trial

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Recruiting
CT.gov ID
NCT04766073
Collaborator
(none)
183
1
2
18.4
10

Study Details

Study Description

Brief Summary

In the last decade we have been exposed to the complication of a caesarean section called a "niche". A niche is an anaerobic defect in the location of the cesarean section, which represents the discontinuity of the endometrium and myometrium. A niche is usually diagnosed by ultrasound, and can also be diagnosed by hysterosalpingogram or hysteroscopy. In the presence of a niche women suffer more frequently from irregular bleeding, dysmenorrhea, chronic pelvic pain, and dyspareunia. We believe that a combination of tissue ischemia and thinning of the scar tissue that forms, causes a niche to form. Large randomized studies regarding the preferred surgical technique in cesarean section, including various methods of incision closure have found that there is no single method that is obviously superior. However, these studies did not examine niche formation as a complication of cesarean section.

In this study we will examine whether a unique incision closure method reduces post-cesarean niche formation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Niche prevention suture
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
183 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Surgical Incision Closure Method to Prevent Niche Formation After Cesarean Section- Randomized Controlled Trial
Actual Study Start Date :
Jul 22, 2021
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: New Closure Technique

This group will have the uterus closed after delivery of the fetus during cesarean section with a new technique.

Procedure: Niche prevention suture
This group will have the uterus sutured in two layers using a new technique.

No Intervention: Regular closure technique

The usual method of closing the surgical incision is to suture the entire wall of the uterus with a stratafix suture without locking the suture.

Outcome Measures

Primary Outcome Measures

  1. Formation of a uterine niche [At least 12 weeks after delivery.]

    Presence of a uterine niche on ultrasound

Secondary Outcome Measures

  1. Duration of surgery [At surgery]

    Total duration of surgery

  2. Blood loss over 1000 mL [At surgery]

    As assessed by the operating surgeon

  3. Postoperative infection [Up to 6 weeks after intervention]

    The number of patients who are diagnosed with postoperative infection including endometritis or wound infection.

  4. Need for repeat laparotomy [Up to 6 weeks after intervention]

    The number of patients who undergo a repeat laparotomy after the initial cesarean delivery will be ascertained.

  5. Formation of a n abscess/hematoma [Up to 6 weeks after intervention]

    The number of patients who are diagnosed with a pelvic abscess or hematoma from the time of the cesarean delivery until 6 weeks after the cesarean delivery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women at first cesarean delivery

  • Women who consent to the study

Exclusion Criteria:
  • Women who are having a repeat caesarean section

  • Refusal to participate in the study

  • Urgent or emergent cesarean delivery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hadassah Medical Organization Jerusalem Israel

Sponsors and Collaborators

  • Hadassah Medical Organization

Investigators

  • Principal Investigator: Hila Hochler, MD, Hadassah Medical Organization

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT04766073
Other Study ID Numbers:
  • 8978006-HMO-CTIL
First Posted:
Feb 23, 2021
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2022